Skip to main content
Clinical Trials/IRCT20201015049030N1
IRCT20201015049030N1
Recruiting
Phase 2

Study of Dexamethasone effects on the improvement of clinical symptoms and laboratory signs of Iranian COVID-19 patients: a clinical trial study

Tehran University of Medical Sciences0 sites200 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
200
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Outpatients with Covid 19 confirmed by positive PCR test for SARS\-CoV\-2 or confirmed by abnormal CT scan finding (bilateral, sub pleural, peripheral ground glass opacities),
  • With blood oxygen saturation between 90\-95%
  • Patients with severe respiratory symptoms such as cough, shortness of breath and severe shortness of breath or CRP above 20 or after three days of standard treatment worsened symptoms of the disease, including exacerbated fevers, aggravated weakness or aggravated shortness of breath based on the physician's clinical judgment

Exclusion Criteria

  • Patients with a history of underlying disease such as diabetes, malignancies, renal and heart failure, uncontrolled hypertension, and taking immunosuppressive drugs and corticosteroids
  • Patients with other active infections
  • Pregnant or lactating women

Outcomes

Primary Outcomes

Not specified

Similar Trials